Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Amgen Inc. et al v. Sanofi et al
Case Number:
1:14-cv-01317
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 16, 2016
Sanofi Says Amgen Patents Doomed Despite Jury Win
A jury's finding that two Amgen patents for a cholesterol drug were valid can't stand, rival Sanofi told a Delaware federal court in a motion Friday, saying the claims of the patents are overbroad and insufficiently described.
-
March 16, 2016
Amgen Patents For Cholesterol Drug Valid, Jury Finds
A Delaware federal jury found that two Amgen Inc. patents for a cholesterol drug were valid, handing the California-based pharmaceutical giant victory over rivals Sanofi SA and Regeneron Pharmaceuticals Inc., Amgen said Wednesday.
- ← Previous
- 1
- 2
- Next →